《港股开市》恒指高开166点 国药及复星医药弹高
美国4月非农就业增长远逊预期,投资者预期美国维持宽松货币政策,道指上周五(7日)再创新高,
收升229点或0.66%。恒指今早高开166点或0.6%,报28,776;国指高开67点或0.6%,报10,766。恒生科技指数高开32点或0.4%,报7,987。
汇控(00005.HK)、友邦(01299.HK)均高开0.5%。中移动(00941.HK)平开报50元。腾讯(00700.HK)子公司Supercell在热门网游功能的专利诉讼中败诉,被判赔付9,220万美元。该股开市跌0.2%,失守600元大关,报599元。
其他科技股个别发展,哔哩哔哩(09626.HK)、美团(03690.HK)、百度(09888.HK)分别低开2.3%、1%、0.3%。阿里巴巴(09988.HK)平开。小米(01810.HK)高开1.2%。创科实业(00669.HK)、药明生物(02269.HK)、申洲国际(02313.HK)高开1.8%-2.8%。
中资金融股表现向好,建行(00939.HK)、工行(01398.HK)分别高开1.4%、0.8%。中石油(00857.HK)、中海油(00883.HK)分别高开1.3%、2.3%。
复星医药(02196.HK)拟与BioNTech合资於内地生产新冠疫苗,股价高开15%。国药(01099.HK)高开7.9%,国药新冠疫苗列入世卫紧急使用清单。
比亚迪(01211.HK)4月汽车产量增44.8%,销量升42.2%,股价高开1%。
铜铝期货价格续升,紫金(02899HK)发行人民币公司债注册申请获批,股价高开4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.